1 Dalle S, "The role of inflammation in age-related sarcopenia" 8 : 1045-, 2017
2 Xue QL, "The frailty syndrome: definition and natural history" 27 : 1-15, 2011
3 Blasko I, "TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs" 13 : 63-68, 1999
4 Batsis JA, "Sarcopenia, sarcopenic obesity and inflammation: results from the 1999-2004 National Health and Nutrition Examination Survey" 35 : 1472-1483, 2016
5 Hida T, "Sarcopenia and physical function are associated with inflam-mation and arteriosclerosis in community-dwelling people: the Yakumo study" 28 : 345-350, 2018
6 Sastre M, "Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists mod-ulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase" 23 : 9796-9804, 2003
7 Heneka MT, "Neuroinflammation in Alzheimer’s disease" 14 : 388-405, 2015
8 Bano G, "Inflammation and sarcopenia: a systematic review and meta-analysis" 96 : 10-15, 2017
9 Büttner R, "Inflammaging impairs peripheral nerve maintenance and regeneration" 17 : e12833-, 2018
10 Frasca D, "Inflammaging decreases adaptive and innate immune responses in mice and humans" 17 : 7-19, 2016
1 Dalle S, "The role of inflammation in age-related sarcopenia" 8 : 1045-, 2017
2 Xue QL, "The frailty syndrome: definition and natural history" 27 : 1-15, 2011
3 Blasko I, "TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs" 13 : 63-68, 1999
4 Batsis JA, "Sarcopenia, sarcopenic obesity and inflammation: results from the 1999-2004 National Health and Nutrition Examination Survey" 35 : 1472-1483, 2016
5 Hida T, "Sarcopenia and physical function are associated with inflam-mation and arteriosclerosis in community-dwelling people: the Yakumo study" 28 : 345-350, 2018
6 Sastre M, "Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists mod-ulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase" 23 : 9796-9804, 2003
7 Heneka MT, "Neuroinflammation in Alzheimer’s disease" 14 : 388-405, 2015
8 Bano G, "Inflammation and sarcopenia: a systematic review and meta-analysis" 96 : 10-15, 2017
9 Büttner R, "Inflammaging impairs peripheral nerve maintenance and regeneration" 17 : e12833-, 2018
10 Frasca D, "Inflammaging decreases adaptive and innate immune responses in mice and humans" 17 : 7-19, 2016
11 Franceschi C, "Inflamm-aging. An evolutionary perspective on immunosenescence" 908 : 244-254, 2000
12 Hak Chul Jang, "How to Diagnose Sarcopenia in Korean Older Adults?" 대한노인병학회 22 (22): 73-79, 2018
13 Fried LP, "Frailty in older adults: evidence for a phenotype" 56 : M146-M156, 2001
14 Wu IC, "Emerging roles of frailty and inflam-maging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine" 5 : 1-, 2015
15 Moo-Young Kim, "Development of a Consensus List of Potentially Inappropriate Medications for Korean Older Adults" 대한노인병학회 22 (22): 121-129, 2018